Do Kwon Young, Wang Xiangchun E, Bender Michael F, Yang Rong, Li Yile, McKee Krisha, Rawi Reda, O'Dell Sijy, Schneck Nicole A, Shaddeau Andrew, Zhang Baoshan, Arnold Frank J, Connors Mark, Doria-Rose Nicole A, Kwong Peter D, Lei Q Paula
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Gaithersburg, MD 20878, USA.
Antibodies (Basel). 2021 Jun 10;10(2):23. doi: 10.3390/antib10020023.
Antibody 10E8 is capable of effectively neutralizing HIV through its recognition of the membrane-proximal external region (MPER), and a suitably optimized version of 10E8 might have utility in HIV therapy and prophylaxis. However, 10E8 displays a three-peak profile on size-exclusion chromatography (SEC), complicating its manufacture. Here we show cis-trans conformational isomerization of the Tyr-Pro-Pro (YPP) motif in the heavy chain 3rd complementarity-determining region (CDR H3) of antibody 10E8 to be the mechanistic basis of its multipeak behavior. We observed 10E8 to undergo slow conformational isomerization and delineate a mechanistic explanation for effective comodifiers that were able to resolve its SEC heterogeneity and to allow an evaluation of the critical quality attribute of aggregation. We determined crystal structures of single and double alanine mutants of a key di-proline motif and of a light chain variant, revealing alternative conformations of the CDR H3. We also replicated both multi-peak and delayed SEC behavior with MPER-antibodies 4E10 and VRC42, by introducing a Tyr-Pro (YP) motif into their CDR H3s. Our results show how a conformationally dynamic CDR H3 can provide the requisite structural plasticity needed for a highly hydrophobic paratope to recognize its membrane-proximal epitope.
抗体10E8能够通过识别膜近端外部区域(MPER)有效中和HIV,对10E8进行适当优化后的版本可能在HIV治疗和预防中具有应用价值。然而,10E8在尺寸排阻色谱(SEC)上呈现三峰图谱,这使其生产变得复杂。在此,我们表明抗体10E8重链第3互补决定区(CDR H3)中Tyr-Pro-Pro(YPP)基序的顺反构象异构化是其多峰行为的机制基础。我们观察到10E8会发生缓慢的构象异构化,并阐述了能够解决其SEC异质性并允许评估聚集关键质量属性的有效共调节剂的机理解释。我们确定了关键二脯氨酸基序的单丙氨酸和双丙氨酸突变体以及轻链变体的晶体结构,揭示了CDR H3的替代构象。我们还通过在MPER抗体4E10和VRC42的CDR H3中引入Tyr-Pro(YP)基序,复制了它们的多峰和延迟SEC行为。我们的结果表明,构象动态的CDR H3如何为高度疏水的互补位提供识别其膜近端表位所需的必要结构可塑性。